AL

Abraham J. Langseth

ST Springworks Therapeutics: 14 patents #3 of 22Top 15%
📍 Stamford, CT: #106 of 1,447 inventorsTop 8%
🗺 Connecticut: #3,182 of 34,797 inventorsTop 10%
Overall (All Time): #330,928 of 4,157,543Top 8%
14
Patents All Time

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDate
12390430 Mirdametinib treatment Uchenna H. Iloeje, Todd Webster Shearer 2025-08-19
12383517 Dosage forms of mirdametinib Piero L. Ruggiero, Kristin Patterson, Mark Hatcher, Jiping Liu, Uchenna H. Iloeje 2025-08-12
12324791 Mirdametinib treatment Uchenna H. Iloeje, Todd Webster Shearer 2025-06-10
12295925 Treatment of neurofibromatosis type 1 (NF1) associated plexiform neurofibromas (PN) in pediatric patients with mirdametinib Uchenna H. Iloeje, Todd Webster Shearer 2025-05-13
12263146 Non-linear dosing of mirdametinib Uchenna H. Iloeje, Todd Webster Shearer 2025-04-01
12257215 Mirdametinib treatment Uchenna H. Iloeje, Todd Webster Shearer 2025-03-25
12220390 Mirdametinib treatment Uchenna H. Iloeje, Todd Webster Shearer 2025-02-11
12029711 Dosage forms of mirdametinib Piero L. Ruggiero, Kristin Patterson, Mark Hatcher, Jiping Liu, Uchenna H. Iloeje 2024-07-09
12011424 Treatment of neurofibromatosis type 1 (NF1) associated plexiform neurofibromas (PN) in pediatric patients with mirdametinib Uchenna H. Iloeje, Todd Webster Shearer 2024-06-18
11883375 Mirdametinib treatment Uchenna H. Iloeje, Todd Webster Shearer 2024-01-30
11839595 Mirdametinib treatment Uchenna H. Iloeje, Todd Webster Shearer 2023-12-12
11819487 Treatment of neurofibromatosis type 1 (NF1) associated plexiform neurofibromas (PN) in pediatric patients with mirdametinib Uchenna H. Iloeje, Todd Webster Shearer 2023-11-21
11806322 Mirdametinib treatment Uchenna H. Iloeje, Todd Webster Shearer 2023-11-07
11806321 Non-linear dosing of mirdametinib Uchenna H. Iloeje, Todd Webster Shearer 2023-11-07